Tezepelumab for severe asthma
Institute for Clinical and Economic Review (ICER)
Record ID 32018002628
English
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://icer.org/asthma-2021/#timeline
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Asthma
- Anti-Asthmatic Agents
- Biological Products
- Antibodies, Monoclonal, Humanized
- Cost-Benefit Analysis
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.